BioLife : Kolon Life Science Launches Osteoarthritis Drug Invossa in Korea
November 15, 2017 at 09:45 pm
Share
15Nov
A huge congratulations to BioLife customer TissueGene / Kolon Life Science on their first patient use of CryoStor - powered Invossa, a novel cell-mediated therapy for degenerative arthritis. Invossa is the world's first gene therapy for treating osteoarthritis of the knee, in which the cartilage that cushions the joints wears away, causing the bones to rub together and induce pain.
A single injection of the drug delivers therapeutic relief for up to two years, according to the firm. It was developed by Kolon Group's US-based bioparma subsidiary TissueGene, which went public on the Kosdaq recently. To read more, visit this article.
BioLife Solutions Inc. published this content on 15 November 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 15 November 2017 21:44:01 UTC.
Original documenthttps://www.biolifesolutions.com/uncategorized/kolon-life-science-launches-osteoarthritis-drug-invossa-korea/
Public permalinkhttp://www.publicnow.com/view/E9DE9ACF6ABE12BB23DCAACFDFFA21D3C8BBDBBA
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.